Credit Suisse’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-34,903
Closed -$75.7K 3453
2022
Q4
$75.7K Sell
34,903
-472
-1% -$3.89K ﹤0.01% 3366
2022
Q3
$423K Buy
35,375
+307
+0.9% +$3.81K ﹤0.01% 2887
2022
Q2
$293K Sell
35,068
-3,186
-8% -$24.7K ﹤0.01% 3175
2022
Q1
$332K Sell
38,254
-1,619
-4% -$15.6K ﹤0.01% 3176
2021
Q4
$451K Buy
39,873
+5,818
+17% +$69.1K ﹤0.01% 3889
2021
Q3
$428K Buy
34,055
+964
+3% +$8.87K ﹤0.01% 3907
2021
Q2
$268K Sell
33,091
-7,233
-18% -$62.7K ﹤0.01% 4161
2021
Q1
$373K Sell
40,324
-51,167
-56% -$516K ﹤0.01% 3921
2020
Q4
$884K Buy
91,491
+6,474
+8% +$63.8K ﹤0.01% 3415
2020
Q3
$1.05M Buy
85,017
+2,158
+3% +$28.6K ﹤0.01% 2883
2020
Q2
$1.08M Buy
82,859
+42,993
+108% +$541K ﹤0.01% 2850
2020
Q1
$404K Sell
39,866
-8,139
-17% -$106K ﹤0.01% 3234
2019
Q4
$750K Buy
48,005
+31,448
+190% +$633K ﹤0.01% 3317
2019
Q3
$277K Buy
16,557
+5,010
+43% +$99.6K ﹤0.01% 3737
2019
Q2
$256K Buy
+11,547
New +$221K ﹤0.01% 3756

Other funds holding GOSS

Credit Suisse's GOSS Position: Q1 2023 in Review

Credit Suisse sold out of Gossamer Bio (GOSS) in Q1 2023, closing a stake of 34,903 shares — an estimated $75.7K sold.

Credit Suisse first reported a position in GOSS in Q2 2019 and held it in 15 quarters. The position peaked at $1.08M in Q2 2020. 111 funds tracked by Wall St. Rank hold GOSS as of Q1 2023.

  • Credit Suisse reported no remaining Gossamer Bio position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 34,903 Gossamer Bio shares in Q1 2023, an estimated $75.7K.
  • Credit Suisse first reported a position in Gossamer Bio in Q2 2019 and held it in 15 quarters.
  • Credit Suisse's Gossamer Bio position peaked at $1.08M in Q2 2020.
  • 111 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.